Skip to content
Informed Portfolio logoInformed Portfolio

ETF · real data, updated daily

VUKE.L Vanguard FTSE 100 Ucits ETF (gbp) Accumulating

Over the last 14 years (2012-052026-09), $10,000 invested in VUKE.L with dividends reinvested grew to $32,7638.58% a year — with a worst peak-to-trough fall of -24.77%. Past performance doesn't predict future results.

Growth of $10,000 · 2012-052026-09 · dividends reinvested

CAGR (annualized return)
8.58%
Volatility (annualized)
11.36%
Worst drawdown
-24.77%
Sharpe ratio
0.64

About VUKE.L

Vanguard FTSE 100 UCITS ETF (GBP) Accumulating is an exchange-traded fund that tracks the FTSE 100 Index, comprising the 100 most highly capitalized blue-chip companies listed on the London Stock Exchange. Launched on May 14, 2019, and domiciled in Ireland, it employs full physical replication by holding all index constituents in the same proportions, ensuring close alignment with benchmark performance. As an accumulating ETF, it reinvests dividends automatically, boosting share price growth without distributions to investors. With a low total expense ratio of 0.09% per annum, it offers cost-efficient exposure to the UK’s largest firms across diverse sectors like financials, healthcare, energy, consumer staples, and industrials. Top holdings include AstraZeneca PLC (8.58%), HSBC Holdings PLC (8.37%), and Shell PLC (6.58%), representing companies with a median market capitalization of £56.8 billion. The fund’s assets exceed €2.2 billion, underscoring its prominence in providing unhedged GBP-denominated access to the UK equity market’s leading enterprises.

Put VUKE.L to the test

Every tool below opens prefilled with VUKE.L — free, no account needed.

Educational use only — not investment advice. Results are hypothetical.Read full disclaimer

This tool is for educational and informational purposes only and does not provide financial, investment, tax, legal, or accounting advice. Results are hypothetical and based on historical data and assumptions that may be inaccurate. Past performance does not guarantee future results. Consult a licensed professional before making investment decisions.